SEPN
SEPN
NASDAQ · Pharmaceuticals

Septerna Inc

$36.08
+0.03 (+0.08%)
As of Jun 25, 1:46 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +24.6% upside
Low Target $33.78
Average Target $44.96
High Target $58.81
Current Price $36.08
Current
$36.08
Target
$44.96
$33.78 $44.96 avg $58.81
Scenario Analysis
Bear Case
$33.78
-6.4%
Low target
Base Case
$44.96
+24.6%
Avg target
Bull Case
$58.81
+63.0%
High target
Risk/Reward
9.9x
Highly favorable
Price in Context
52-Week High
$37.32
-3.3% from high
52-Week Low
$9.85
+266.2% from low
Target vs 52W High
$44.96
+20.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.3%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.2%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.7%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +42.3%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +170.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%